A detailed history of Monumental Financial Group Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Monumental Financial Group Inc. holds 2,036 shares of LLY stock, worth $1.52 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
2,036
Previous 2,334 12.77%
Holding current value
$1.52 Million
Previous $2.11 Million 14.67%
% of portfolio
0.67%
Previous 0.93%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$772.14 - $960.02 $230,097 - $286,085
-298 Reduced 12.77%
2,036 $1.8 Million
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $266,027 - $333,617
-367 Reduced 13.59%
2,334 $2.11 Million
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $60,404 - $80,812
-102 Reduced 3.64%
2,701 $2.1 Million
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $56,720 - $66,866
-108 Reduced 3.71%
2,803 $1.63 Million
Q3 2023

Oct 13, 2023

BUY
$434.7 - $599.3 $43,035 - $59,330
99 Added 3.52%
2,911 $1.56 Million
Q2 2023

Jul 11, 2023

SELL
$350.74 - $468.98 $207,287 - $277,167
-591 Reduced 17.37%
2,812 $1.32 Million
Q1 2023

May 03, 2023

BUY
$310.63 - $364.82 $56,534 - $66,397
182 Added 5.65%
3,403 $1.17 Million
Q4 2022

Jan 30, 2023

BUY
$321.55 - $374.67 $832,492 - $970,020
2,589 Added 409.65%
3,221 $1.18 Million
Q3 2022

Oct 13, 2022

BUY
$296.48 - $337.87 $187,375 - $213,533
632 New
632 $204,000
Q2 2022

Jul 28, 2022

SELL
$278.73 - $327.27 $62,435 - $73,308
-224 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $52,570 - $65,331
224 New
224 $64,000
Q3 2021

Oct 18, 2021

SELL
$221.6 - $272.71 $41,217 - $50,724
-186 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $615,314 - $795,904
-3,408 Reduced 94.82%
186 $43,000
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $590,566 - $764,515
3,594 New
3,594 $671,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $711B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Monumental Financial Group Inc. Portfolio

Follow Monumental Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monumental Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Monumental Financial Group Inc. with notifications on news.